Skip to main content

Table 2 Baseline parameters showing transition probabilities associated with BPH treatment

From: A cost effective analysis of fixed-dose combination of dutasteride and tamsulosin compared with dutasteride monotherapy for benign prostatic hyperplasia in Nigeria: a middle income perspective; using an interactive Markov model

Transitions (from-to) Average annual probability
Min, max Dutasteride therapy Combination therapy
Health to mild BPH 0.29 0.29
Mild BPH to moderate BPH 0.29 0.29
Moderate to severe BPH 0.16 0.058
Moderate/severe to AUR 0.13 0.04
Moderate/severe to TURP 0.16 0.056
TURP to repeat TURP 0.48 0.48
Severe to moderate BPH 0.46 0.49
Moderate to mild BPH 0.46 0.49
Death rate 0.013 0.013